Duke Debates: Controversies in the Management of Patients with Hematologic Malignancies

March 14, 2014 to March 16, 2014

Learning Objectives

  • Identify appropriate use of pathology to incorporate minimal residual disease monitoring into acute myeloid leukemia therapy plans
  • Identify emerging data and recent advances in the treatment of patients with hematologic malignancies
  • Identify the benefits of the different treatment options for the management hematology disorders 
Course summary
Available credit: 
  • 13.50 AMA PRA Category 1 Credit(s)
  • 13.50 Attendance
Registration Opens: 
01/30/2014
Registration Expires: 
09/16/2014
Activity Starts: 
03/14/2014 - 1:00pm
Activity Ends: 
03/16/2014 - 11:10am
Mills House
Charleston, SC
United States
Martha Lassiter
Doug Gladstone
Jennifer Frith
Charles Bolan, Jr.
Therese Henning
Tiffany Christensen
Carlos DeCastro
Mitchell Cairo
Arati Rao
Anand Sheeram Lagoo
Cristina Gasparetto
David Rizzieri
Joseph Moore
Ara Metjian
Gow Arepally
Thomas Ortel
Mitchell Horwitz
Richard Lopez
Danielle Brander
Louis Diehl
 

Available Credit

  • 13.50 AMA PRA Category 1 Credit(s)
  • 13.50 Attendance
Please login or register to take this course.